|
|||
Identifiers | |||
---|---|---|---|
3D model (Jmol)
|
|||
ChemSpider | |||
ECHA InfoCard | 100.013.697 | ||
PubChem CID
|
|||
|
|||
|
|||
Properties | |||
C10H10Cl2Zr | |||
Molar mass | 292.31 g·mol−1 | ||
Appearance | white solid | ||
Soluble (Hydrolysis) | |||
Hazards | |||
Safety data sheet | CAMEO Chemicals MSDS | ||
Related compounds | |||
Related compounds
|
Titanocene dichloride Hafnocene dichloride Vanadocene dichloride Niobocene dichloride Tanatalocene dichloride Tungstenoocene dichloride |
||
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|||
what is ?) | (|||
Infobox references | |||
Zirconocene dichloride is an organozirconium compound composed of a zirconium central atom, with two cyclopentadienyl and two chloro ligands. It is a colourless diamagnetic solid that is somewhat stable in air.
Zirconocene dichloride may be prepared from zirconium(IV) chloride-THF complex and sodium cyclopentadienide:
The closely related compound Cp2ZrBr2 was first described by Birmingham and Wilkinson.
The compound is a bent metallocene: the Cp rings are not parallel, the average Cp(centroid)-M-Cp angle being 128°. The Cl-Zr-Cl angle of 97.1° is wider than in niobocene dichloride (85.6°) and molybdocene dichloride (82°). This trend helped to establish the orientation of the HOMO in this class of complex.
Zirconocene dichloride reacts with lithium aluminium hydride to give Cp2ZrHCl Schwartz's reagent:
Since lithium aluminium hydride is a strong reductant, some over-reduction occurs to give the dihydrido complex, Cp2ZrH2; treatment of the product mixture with methylene chloride converts it to Schwartz's reagent.
Zirconocene dichloride can also be used to prepare the Negishi reagent, Cp2Zr(η2-butene) which is used as a source for Cp2Zr in oxidative cyclisation reactions. This reagent is prepared by treating zirconacene dichloride with n-BuLi leading to replacement of the two chloride ligands with butyl. The dibutyl compound subsequently undergoes beta-hydrogen abstraction to give one η2-butene ligand, eliminating the other butyl ligand as butane.